LMNA Q353R Mutation Causes Dilated Cardiomyopathy Through Impaired Vitamin D Signaling

Affiliations

• ¹ Department of Cardiovascular Medicine (M. Ito, M. Katoh, T.S., T.K., K.F., S.Y., M. Katagiri, M. Kubota, T.Y., S.H., H.M., S.N., I.K.), Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
• ² Department of Advanced Clinical Science and Therapeutics (M. Ito), Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
• ³ Department of Frontier Cardiovascular Science (M. Katoh, T.K., S.N., I.K.), Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
• ⁴ Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Meguro-ku, Japan (M. Katoh, S.N., H.A.).
• ⁵ Institute of Advanced Biomedical Engineering and Science (K. Miura, K. Matsuura), Tokyo Women's Medical University, Shinjuku-ku, Japan.
• ⁶ Center for Regenerative Medicine (M.T., A.U.), National Center for Child Health and Development Research Institute, Setagaya-ku, Tokyo, Japan.
• ⁷ Department of Systems BioMedicine (S.T.), National Center for Child Health and Development Research Institute, Setagaya-ku, Tokyo, Japan.
• ⁸ Department of Cardiology (T.T.), Tokyo Women's Medical University, Shinjuku-ku, Japan.
• ⁹ Department of Biodesign, Division of Biofunctional Restoration Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Japan (M. Ikeuchi).
• ¹⁰ International University of Health and Welfare, Minato-ku, Tokyo, Japan (I.K.).